Pages that link to "Q36149981"
Jump to navigation
Jump to search
The following pages link to Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. (Q36149981):
Displaying 50 items.
- Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications (Q26740418) (← links)
- Recent advances in the application of metabolomics to Alzheimer's Disease (Q26828606) (← links)
- Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation (Q28087030) (← links)
- Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties (Q28547451) (← links)
- Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse (Q30363059) (← links)
- Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia (Q33627250) (← links)
- Circulating biomarkers that predict incident dementia (Q33752058) (← links)
- Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease (Q33964297) (← links)
- Is Alzheimer's disease a systemic disease? (Q34019193) (← links)
- Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease (Q34223125) (← links)
- Blockade of lysosomal acid ceramidase induces GluN2B-dependent Tau phosphorylation in rat hippocampal slices. (Q34223486) (← links)
- Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics (Q34422726) (← links)
- Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study (Q34994293) (← links)
- Emerging biomarkers in cognition (Q35008258) (← links)
- Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study (Q35065194) (← links)
- The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden (Q36121819) (← links)
- Interictal, circulating sphingolipids in women with episodic migraine: A case-control study (Q36166971) (← links)
- The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome. (Q36209750) (← links)
- Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species (Q36409995) (← links)
- HDL-cholesterol and apolipoproteins in relation to dementia (Q36436743) (← links)
- Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease? (Q36768801) (← links)
- Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology (Q36858639) (← links)
- Peripheral sphingolipids are associated with variation in white matter microstructure in older adults (Q36973077) (← links)
- Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study (Q37091714) (← links)
- Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma (Q37109693) (← links)
- Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab. (Q37389500) (← links)
- Sphingolipids and lifespan regulation (Q37586487) (← links)
- APP Function and Lipids: A Bidirectional Link (Q37692220) (← links)
- Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. (Q38125769) (← links)
- Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease (Q38262863) (← links)
- Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies (Q38607507) (← links)
- Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance (Q38833111) (← links)
- Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid. (Q39181900) (← links)
- Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. (Q39320214) (← links)
- Lipidomic Profiles in Diabetes and Dementia. (Q39352421) (← links)
- The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging. (Q40401973) (← links)
- Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease (Q40444820) (← links)
- Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection (Q41687237) (← links)
- Markedly perturbed hematopoiesis in acid ceramidase deficient mice (Q42573873) (← links)
- The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease (Q43988916) (← links)
- Genetic variation modifies risk for neurodegeneration based on biomarker status. (Q46000358) (← links)
- Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents. (Q46426783) (← links)
- Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease (Q46563505) (← links)
- Skeletal muscle ceramide species in men with abdominal obesity (Q46753548) (← links)
- Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway (Q47099182) (← links)
- A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise. (Q47146081) (← links)
- Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F. (Q47407341) (← links)
- Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications (Q47619472) (← links)
- The serum metabolomics signature of Type 2 Diabetes is obscured in Alzheimer's Disease (Q49917617) (← links)
- Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans (Q50481966) (← links)